Loading resource…

Fukushima Medical University School of Medicine, Teikyo University School of Medicine
Autoimmune hepatitis (AIH) is an autoimmune liver disease characterized by immune-mediated hepatocellular destruction. Recent epidemiological data indicate a significant increase in both the incidence and prevalence of AIH worldwide, emphasizing potential shifts in environmental triggers and heightened disease awareness. The review discusses updated diagnostic criteria and management strategies, including the use of immunosuppressive therapy and the importance of achieving biochemical response for better long-term outcomes.
No account needed